Canada authorises Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15

TORONTO: Canada is authorising the use of Pfizer's COVID-19 vaccine for use in children from the ages of 12 to 15, the first dose to be allowed for people that young, the federal health ministry said on Wednesday (May 5).

"The department determined that this vaccine is safe and effective when used in this younger age group," Supriya Sharma, a senior adviser at the ministry, told a briefing. "We are starting to see the light at the end of the tunnel."

READ: Pfizer sees robust COVID-19 vaccine demand for years, US$26 billion in 2021 sales

Canada's federal government has bought tens of millions of doses of vaccines but critics complain the pace of inoculation is lagging amid bottlenecks in the 10 provinces, which are responsible for administering the doses.

Sharma said Pfizer, which is working with German partner BioNTech SE, would be required to provide information on the safety, efficacy and quality of the vaccine in the 12 to 15 age group.

About 20 per cent of the 1,249,950 cases of COVID-19 in Canada have been reported in people under the age of 19. Canada has also recorded 24,396 deaths.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram